Dexcom CEO talks Stelo sensor launch, OTC strategy
Dexcom CEO Kevin Sayer shared new data on the company’s first over-the-counter glucose sensor at the J.P. Morgan Healthcare Conference on Monday. Stelo, which is indicated for people who don’t take insulin, had about 140,000 users at the end of the year. …